Gilead
- All
- News
- Videos
-
Drugmaker Gilead To Fund Monkeypox Education For LGBTQ+ Groups
Gilead is a leading producer of therapies to treat HIV. The company said it is also evaluating whether any of its treatments or experimental drug candidates could be effective against monkeypox.
-
6.1 Lakh Remdesivir Vials, Oxygen Aid From Abroad Sent To States: Centre
Nineteen oxygen generation plants, 11,325 oxygen concentrators, 15,801 oxygen cylinders and about 6.1 lakh Remdesivir vials received as global aid have been dispatched to various states and Union territories from April 27 to May 17, the Centre said.
-
25,000 Doses Of Remdesivir From Gilead Sciences Reach India
The third consignment consisting of 25000 doses of Remdesivir from American biopharmaceutical company Gilead Sciences reached India on Saturday.
-
US Drugmaker To Donate 400,000 Covid Treatment Tablets To India
Eli Lilly and Co said on Tuesday it would supply 400,000 tablets of its COVID-19 treatment, to be used with Gilead's remdesivir, to India as the country fights a raging pandemic that has morgues and hospitals overflowing.
-
India To Import 4,50,000 Vials Of Anti-Viral Drug Remdesivir: Centre Amid Shortage
The government of India has started importing anti-viral drug Remdesivir from other countries and the first consignment of 75,000 vials will reach India today amid the ongoing Covid pandemic, Union Ministry of Chemicals and Fertilisers has said.
-
US Firm To Expand Remdesivir Availability In India; Donate 4.5 Lakh Vials
US Drug firm Gilead Sciences said it is taking several steps to expand the availability of antiviral drug Remdesivir in India and will also be donating a minimum of 4.5 lakh vials of 'Veklury' to the Indian government.
-
US Pharma Firm Gilead To Donate 4.5 Lakh Remdesivir Vials To India
American biopharmaceutical company Gilead has announced steps to expand the availability of remdesivir, a key therapeutic medicine used in the treatment of COVID-19 patients, in India.
-
India Seeks Remdesivir, Oxygen From EU, Aid Expected Soon: EU Official
India has asked the European Union to send medical oxygen and Gilead's antiviral drug remdesivir to fight a surge in COVID-19 cases, an EU official said on Monday, adding that the aid could be made available soon.
-
WHO Removes Remdesivir From List Of Medicines Used As Benchmark
The World Health Organization said on Friday it has suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised COVID-19 patients.
-
WHO Says No Evidence Remdesivir Improves Survival, Gilead "Disappointed"
The World Health Organization recommended against using Gilead Sciences Inc.'s remdesivir to treat hospitalized Covid-19 patients less than a month after U.S. regulators granted the drug a speedy approval.
-
WHO-Led Covid Drug Scheme Doubles Down On Antibodies, Steroids And Shuns Remdesivir
A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but is shunning Gilead's remdesivir blockbuster therapy, an internal document shows.
-
Nations Eyeing Gilead's Covid Drug Should Take Note Of Failed Trial: WHO
Health officials reviewing Gilead Science Inc's remdesivir against COVID-19 should consider all evidence, including a trial in which the medicine failed, before giving it the green light, the top WHO scientist said on Friday.
-
WHO Defends Data After Concluding Gilead's Remdesivir Flopped Covid Trial
A World Health Organization (WHO) trial that concluded Gilead Sciences Inc.'s remdesivir did not significantly help COVID-19 patients is reliable, a scientist who evaluated the data said on Friday, as the U.S. company criticized its methodology.
-
Remdesivir Didn't Cut Hospital Stay Or Mortality In Covid Patients: WHO
Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
-
Fight Against COVID-19 Clearest Example Of US-India Partnership: US Official
India and the US are equipped to address a range of challenges for the benefit of the world and the clearest example of this can be seen in the partnership between the two countries to fight the COVID-19 pandemic, a senior State Department official has said.
-
Drugmaker Gilead To Fund Monkeypox Education For LGBTQ+ Groups
Gilead is a leading producer of therapies to treat HIV. The company said it is also evaluating whether any of its treatments or experimental drug candidates could be effective against monkeypox.
-
6.1 Lakh Remdesivir Vials, Oxygen Aid From Abroad Sent To States: Centre
Nineteen oxygen generation plants, 11,325 oxygen concentrators, 15,801 oxygen cylinders and about 6.1 lakh Remdesivir vials received as global aid have been dispatched to various states and Union territories from April 27 to May 17, the Centre said.
-
25,000 Doses Of Remdesivir From Gilead Sciences Reach India
The third consignment consisting of 25000 doses of Remdesivir from American biopharmaceutical company Gilead Sciences reached India on Saturday.
-
US Drugmaker To Donate 400,000 Covid Treatment Tablets To India
Eli Lilly and Co said on Tuesday it would supply 400,000 tablets of its COVID-19 treatment, to be used with Gilead's remdesivir, to India as the country fights a raging pandemic that has morgues and hospitals overflowing.
-
India To Import 4,50,000 Vials Of Anti-Viral Drug Remdesivir: Centre Amid Shortage
The government of India has started importing anti-viral drug Remdesivir from other countries and the first consignment of 75,000 vials will reach India today amid the ongoing Covid pandemic, Union Ministry of Chemicals and Fertilisers has said.
-
US Firm To Expand Remdesivir Availability In India; Donate 4.5 Lakh Vials
US Drug firm Gilead Sciences said it is taking several steps to expand the availability of antiviral drug Remdesivir in India and will also be donating a minimum of 4.5 lakh vials of 'Veklury' to the Indian government.
-
US Pharma Firm Gilead To Donate 4.5 Lakh Remdesivir Vials To India
American biopharmaceutical company Gilead has announced steps to expand the availability of remdesivir, a key therapeutic medicine used in the treatment of COVID-19 patients, in India.
-
India Seeks Remdesivir, Oxygen From EU, Aid Expected Soon: EU Official
India has asked the European Union to send medical oxygen and Gilead's antiviral drug remdesivir to fight a surge in COVID-19 cases, an EU official said on Monday, adding that the aid could be made available soon.
-
WHO Removes Remdesivir From List Of Medicines Used As Benchmark
The World Health Organization said on Friday it has suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised COVID-19 patients.
-
WHO Says No Evidence Remdesivir Improves Survival, Gilead "Disappointed"
The World Health Organization recommended against using Gilead Sciences Inc.'s remdesivir to treat hospitalized Covid-19 patients less than a month after U.S. regulators granted the drug a speedy approval.
-
WHO-Led Covid Drug Scheme Doubles Down On Antibodies, Steroids And Shuns Remdesivir
A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but is shunning Gilead's remdesivir blockbuster therapy, an internal document shows.
-
Nations Eyeing Gilead's Covid Drug Should Take Note Of Failed Trial: WHO
Health officials reviewing Gilead Science Inc's remdesivir against COVID-19 should consider all evidence, including a trial in which the medicine failed, before giving it the green light, the top WHO scientist said on Friday.
-
WHO Defends Data After Concluding Gilead's Remdesivir Flopped Covid Trial
A World Health Organization (WHO) trial that concluded Gilead Sciences Inc.'s remdesivir did not significantly help COVID-19 patients is reliable, a scientist who evaluated the data said on Friday, as the U.S. company criticized its methodology.
-
Remdesivir Didn't Cut Hospital Stay Or Mortality In Covid Patients: WHO
Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
-
Fight Against COVID-19 Clearest Example Of US-India Partnership: US Official
India and the US are equipped to address a range of challenges for the benefit of the world and the clearest example of this can be seen in the partnership between the two countries to fight the COVID-19 pandemic, a senior State Department official has said.
